Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001628280-23-041967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-15 | ARWR | PERRY MICHAEL S | Dir | A - Grant | $25.41 | +15.0K | 114.8K | +15% | +$380.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | A | A | 14,987 | $25.41 | 114,754 | D | — | — | (F1) Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary of the grant date. |